Omenn disease: termination in lymphoma.

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Omenn's disease is a rare, autosomal-recessive primary immunodeficiency disorder.
• Characterized by severe combined immunodeficiency, autoimmunity, and early-onset mortality.
• The underlying pathogenesis of Omenn's disease is not fully understood.

Observation:

• Two brothers diagnosed with Omenn's disease were managed at the University of Wisconsin.
• The first sibling deceased at three months of age.
• The second sibling developed a persistent measles infection following live virus vaccination, failing to mount an antibody response.

Findings:

• The second patient received transfer factor and irradiated leukocyte infusions, which provided no clinical benefit.
• Post-mortem examination revealed widespread lymphoma in virtually all tissues.
• The potential role of therapeutic interventions in predisposing to or causing the lymphoma is undetermined.

Implications:

• This case highlights the severe clinical manifestations and poor prognosis of Omenn's disease.
• It raises questions about the safety of live viral vaccines in infants with suspected or confirmed primary immunodeficiencies.
• Further research into Omenn's disease pathogenesis is crucial for developing effective treatments and understanding potential iatrogenic risks.